1 Market Overview
1.1 Hepatitis A and B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepatitis A and B Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hepatitis A Vaccination
1.2.3 Hepatitis B Vaccination
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepatitis A and B Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A and B Vaccine Market Size & Forecast
1.4.1 Global Hepatitis A and B Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hepatitis A and B Vaccine Sales in Volume (2017-2028)
1.4.3 Global Hepatitis A and B Vaccine Price (2017-2028)
1.5 Global Hepatitis A and B Vaccine Production Capacity Analysis
1.5.1 Global Hepatitis A and B Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Hepatitis A and B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepatitis A and B Vaccine Market Drivers
1.6.2 Hepatitis A and B Vaccine Market Restraints
1.6.3 Hepatitis A and B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Hepatitis A and B Vaccine Product and Services
2.1.4 GSK Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Hepatitis A and B Vaccine Product and Services
2.2.4 Merck Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Hepatitis A and B Vaccine Product and Services
2.3.4 Sanofi Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Hepatitis A and B Vaccine Product and Services
2.4.4 Sinovac Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Product and Services
2.5.4 Zhejiang Pukang Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Product and Services
2.6.4 Changchun Institute of Biological Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Hepatitis A and B Vaccine Product and Services
2.7.4 KM Biologics Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IMBCAMS
2.8.1 IMBCAMS Details
2.8.2 IMBCAMS Major Business
2.8.3 IMBCAMS Hepatitis A and B Vaccine Product and Services
2.8.4 IMBCAMS Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Convac
2.9.1 Convac Details
2.9.2 Convac Major Business
2.9.3 Convac Hepatitis A and B Vaccine Product and Services
2.9.4 Convac Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Hepatitis A and B Vaccine Product and Services
2.10.4 NCPC Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bio Kangtai
2.11.1 Bio Kangtai Details
2.11.2 Bio Kangtai Major Business
2.11.3 Bio Kangtai Hepatitis A and B Vaccine Product and Services
2.11.4 Bio Kangtai Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Dynavax
2.12.1 Dynavax Details
2.12.2 Dynavax Major Business
2.12.3 Dynavax Hepatitis A and B Vaccine Product and Services
2.12.4 Dynavax Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Hepatitis A and B Vaccine Product and Services
2.13.4 Hissen Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 LG Life Sciences
2.14.1 LG Life Sciences Details
2.14.2 LG Life Sciences Major Business
2.14.3 LG Life Sciences Hepatitis A and B Vaccine Product and Services
2.14.4 LG Life Sciences Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Serum Institute
2.15.1 Serum Institute Details
2.15.2 Serum Institute Major Business
2.15.3 Serum Institute Hepatitis A and B Vaccine Product and Services
2.15.4 Serum Institute Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hepatitis A and B Vaccine Breakdown Data by Manufacturer
3.1 Global Hepatitis A and B Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hepatitis A and B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hepatitis A and B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Hepatitis A and B Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Hepatitis A and B Vaccine Manufacturer Market Share in 2021
3.5 Global Hepatitis A and B Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hepatitis A and B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hepatitis A and B Vaccine Market Size by Region
4.1.1 Global Hepatitis A and B Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Hepatitis A and B Vaccine Revenue by Region (2017-2028)
4.2 North America Hepatitis A and B Vaccine Revenue (2017-2028)
4.3 Europe Hepatitis A and B Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Hepatitis A and B Vaccine Revenue (2017-2028)
4.5 South America Hepatitis A and B Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Hepatitis A and B Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hepatitis A and B Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Hepatitis A and B Vaccine Revenue by Type (2017-2028)
5.3 Global Hepatitis A and B Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hepatitis A and B Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Hepatitis A and B Vaccine Revenue by Application (2017-2028)
6.3 Global Hepatitis A and B Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hepatitis A and B Vaccine Sales by Type (2017-2028)
7.2 North America Hepatitis A and B Vaccine Sales by Application (2017-2028)
7.3 North America Hepatitis A and B Vaccine Market Size by Country
7.3.1 North America Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Hepatitis A and B Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hepatitis A and B Vaccine Sales by Type (2017-2028)
8.2 Europe Hepatitis A and B Vaccine Sales by Application (2017-2028)
8.3 Europe Hepatitis A and B Vaccine Market Size by Country
8.3.1 Europe Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Hepatitis A and B Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hepatitis A and B Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Hepatitis A and B Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Hepatitis A and B Vaccine Market Size by Region
9.3.1 Asia-Pacific Hepatitis A and B Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hepatitis A and B Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hepatitis A and B Vaccine Sales by Type (2017-2028)
10.2 South America Hepatitis A and B Vaccine Sales by Application (2017-2028)
10.3 South America Hepatitis A and B Vaccine Market Size by Country
10.3.1 South America Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Hepatitis A and B Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hepatitis A and B Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Hepatitis A and B Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Hepatitis A and B Vaccine Market Size by Country
11.3.1 Middle East & Africa Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hepatitis A and B Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hepatitis A and B Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hepatitis A and B Vaccine
12.3 Hepatitis A and B Vaccine Production Process
12.4 Hepatitis A and B Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hepatitis A and B Vaccine Typical Distributors
13.3 Hepatitis A and B Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界のA型＆B型肝炎ワクチン市場2022年：A型肝炎ワクチン接種、B型肝炎ワクチン接種 |
| 【英語タイトル】Global Hepatitis A and B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22NO19376 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2022年11月2日（※2025年版があります。お問い合わせください。） ・ページ数：118 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| A型＆B型肝炎ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のA型＆B型肝炎ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 A型＆B型肝炎ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・A型肝炎ワクチン接種、B型肝炎ワクチン接種 用途別セグメントは次のように区分されます。 ・政府機関、民間、その他 世界のA型＆B型肝炎ワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、Convac、NCPC、Bio Kangtai、Dynavax、Hissen、LG Life Sciences、Serum Institute 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、A型＆B型肝炎ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なA型＆B型肝炎ワクチンメーカーの企業概要、2019年～2022年までのA型＆B型肝炎ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なA型＆B型肝炎ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別A型＆B型肝炎ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのA型＆B型肝炎ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのA型＆B型肝炎ワクチン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびA型＆B型肝炎ワクチンの産業チェーンを掲載しています。 ・第13、14、15章では、A型＆B型肝炎ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - A型＆B型肝炎ワクチンの概要 - 種類別分析（2017年vs2021年vs2028年）：A型肝炎ワクチン接種、B型肝炎ワクチン接種 - 用途別分析（2017年vs2021年vs2028年）：政府機関、民間、その他 - 世界のA型＆B型肝炎ワクチン市場規模・予測 - 世界のA型＆B型肝炎ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、Convac、NCPC、Bio Kangtai、Dynavax、Hissen、LG Life Sciences、Serum Institute ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：A型肝炎ワクチン接種、B型肝炎ワクチン接種 ・用途別分析2017年-2028年：政府機関、民間、その他 ・A型＆B型肝炎ワクチンの北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・A型＆B型肝炎ワクチンのヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・A型＆B型肝炎ワクチンのアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・A型＆B型肝炎ワクチンの南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・A型＆B型肝炎ワクチンの中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hepatitis A and B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hepatitis A and B Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Government Institution accounting for % of the Hepatitis A and B Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hepatitis A Vaccination segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hepatitis A and B Vaccine include GSK, Merck, Sanofi, Sinovac, and Zhejiang Pukang, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hepatitis A and B Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatitis A Vaccination
Hepatitis B Vaccination
Market segment by Application can be divided into
Government Institution
Private Sector
Other
The key market players for global Hepatitis A and B Vaccine market are listed below:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A and B Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis A and B Vaccine, with price, sales, revenue and global market share of Hepatitis A and B Vaccine from 2019 to 2022.
Chapter 3, the Hepatitis A and B Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A and B Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hepatitis A and B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hepatitis A and B Vaccine.
Chapter 13, 14, and 15, to describe Hepatitis A and B Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
| ★調査レポート[世界のA型＆B型肝炎ワクチン市場2022年：A型肝炎ワクチン接種、B型肝炎ワクチン接種] (コード：GIR22NO19376)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のA型＆B型肝炎ワクチン市場2022年：A型肝炎ワクチン接種、B型肝炎ワクチン接種]についてメールでお問い合わせ |
